It is increasingly becoming a national security issue
Additional outcomes data supporting the results of FLOW were released in 2025
Setmelanotide, a novel, selective melanocortin receptor-4 agonist exerts anti-inflammatory actions in astrocytes and promotes an anti-inflammatory macrophage phenotype
[email protected] Stanwood is a developmental neuropharmacologist and behavioral neuroscientist
Symptoms I Pay Attention To Unusual fatigue Rapid heart rate New digestive issues Anxiety or restlessness Drastic changes in hunger Red Flags Patients Often Ignore Feeling extremely cold Consistent brain fog Dramatic hair shedding No weight loss after 12+ weeks These can signal dose adjustments for thyroid medication, not a problem with GLP-1
By contrast, diminished levels of delta wave activity are commonly seen in cases of brain injury, insomnia, narcolepsy, severe ADHD, and neurocognitive disorders [29, 30, 31, 32]